Credit Suisse’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $49.3M | Sell |
124,664
-7,856
| -6% | -$2.91M | 0.05% | 375 |
|
|
2023
Q4 | $46.7M | Sell |
132,520
-1,295
| -1% | -$458K | 0.05% | 411 |
|
|
2023
Q3 | $50.2M | Sell |
133,815
-21,990
| -14% | -$8.5M | 0.05% | 372 |
|
|
2023
Q2 | $59.6M | Sell |
155,805
-4,274
| -3% | -$1.53M | 0.06% | 339 |
|
|
2023
Q1 | $55.5M | Buy |
160,079
+23,629
| +17% | +$6.9M | 0.06% | 362 |
|
|
2022
Q4 | $32.1M | Buy |
136,450
+6,906
| +5% | +$1.64M | 0.03% | 538 |
|
|
2022
Q3 | $31.9M | Sell |
129,544
-2,419
| -2% | -$737K | 0.04% | 518 |
|
|
2022
Q2 | $39.9M | Buy |
131,963
+3,121
| +2% | +$1.02M | 0.04% | 469 |
|
|
2022
Q1 | $52.9M | Buy |
128,842
+7,795
| +6% | +$3.05M | 0.05% | 423 |
|
|
2021
Q4 | $56.8M | Buy |
121,047
+2,039
| +2% | +$878K | 0.03% | 571 |
|
|
2021
Q3 | $50.5M | Sell |
119,008
-10,896
| -8% | -$4.59M | 0.03% | 636 |
|
|
2021
Q2 | $46.8M | Buy |
129,904
+23,698
| +22% | +$7.83M | 0.02% | 726 |
|
|
2021
Q1 | $29.9M | Sell |
106,206
-15,697
| -13% | -$4.49M | 0.02% | 956 |
|
|
2020
Q4 | $34.5M | Buy |
121,903
+7,801
| +7% | +$2.19M | 0.02% | 873 |
|
|
2020
Q3 | $31.4M | Sell |
114,102
-5,706
| -5% | -$1.51M | 0.02% | 806 |
|
|
2020
Q2 | $27.2M | Buy |
119,808
+10,116
| +9% | +$1.99M | 0.02% | 797 |
|
|
2020
Q1 | $16.7M | Buy |
109,692
+19,795
| +22% | +$3.05M | 0.01% | 925 |
|
|
2019
Q4 | $13.5M | Buy |
89,897
+5,431
| +6% | +$791K | 0.01% | 1247 |
|
|
2019
Q3 | $12M | Sell |
84,466
-12,997
| -13% | -$1.79M | 0.01% | 1208 |
|
|
2019
Q2 | $12.2M | Buy |
97,463
+23,251
| +31% | +$2.74M | 0.01% | 1201 |
|
|
2019
Q1 | $8.18M | Buy |
74,212
+12,327
| +20% | +$1.28M | 0.01% | 1366 |
|
|
2018
Q4 | $6.07M | Sell |
61,885
-23,771
| -28% | -$2.58M | 0.01% | 1459 |
|
|
2018
Q3 | $10.6M | Buy |
85,656
+11,068
| +15% | +$1.24M | 0.01% | 1216 |
|
|
2018
Q2 | $7.41M | Sell |
74,588
-13,768
| -16% | -$1.27M | 0.01% | 1449 |
|
|
2018
Q1 | $7.8M | Sell |
88,356
-19,251
| -18% | -$1.8M | 0.01% | 1406 |
|
|
2017
Q4 | $10.6M | Buy |
107,607
+14,843
| +16% | +$1.46M | 0.01% | 1246 |
|
|
2017
Q3 | $8.93M | Buy |
92,764
+2,131
| +2% | +$193K | 0.01% | 1322 |
|
|
2017
Q2 | $8.57M | Sell |
90,633
-965
| -1% | -$88.8K | 0.01% | 1292 |
|
|
2017
Q1 | $7.48M | Sell |
91,598
-181
| -0.2% | -$15.1K | 0.01% | 1374 |
|
|
2016
Q4 | $7.79M | Sell |
91,779
-189,576
| -67% | -$14.9M | 0.01% | 1357 |
|
|
2016
Q3 | $21M | Sell |
281,355
-36,168
| -11% | -$2.87M | 0.02% | 798 |
|
|
2016
Q2 | $24.1M | Buy |
317,523
+249,047
| +364% | +$18.1M | 0.03% | 669 |
|
|
2016
Q1 | $4.75M | Sell |
68,476
-11,108
| -14% | -$668K | 0.01% | 1574 |
|
|
2015
Q4 | $4.79M | Sell |
79,584
-26,132
| -25% | -$1.57M | 0.01% | 1613 |
|
|
2015
Q3 | $5.72M | Buy |
105,716
+56,696
| +116% | +$3.3M | 0.01% | 1467 |
|
|
2015
Q2 | $2.85M | Buy |
49,020
+7,413
| +18% | +$414K | ﹤0.01% | 2256 |
|
|
2015
Q1 | $2.5M | Buy |
41,607
+4,778
| +13% | +$255K | ﹤0.01% | 2203 |
|
|
2014
Q4 | $1.96M | Buy |
36,829
+11,769
| +47% | +$589K | ﹤0.01% | 2552 |
|
|
2014
Q3 | $1.12M | Sell |
25,060
-119,392
| -83% | -$5.07M | ﹤0.01% | 2953 |
|
|
2014
Q2 | $6.09M | Buy |
144,452
+67,517
| +88% | +$2.89M | 0.01% | 1778 |
|
|
2014
Q1 | $3.39M | Sell |
76,935
-6,558
| -8% | -$309K | ﹤0.01% | 2084 |
|
|
2013
Q4 | $4.1M | Buy |
83,493
+20,908
| +33% | +$978K | ﹤0.01% | 2004 |
|
|
2013
Q3 | $2.58M | Buy |
62,585
+26,917
| +75% | +$1.03M | ﹤0.01% | 2181 |
|
|
2013
Q2 | $1.25M | Buy |
+35,668
| New | +$1.17M | ﹤0.01% | 2619 |
|
Other funds holding WST
Credit Suisse's WST Position: Q1 2024 in Review
Credit Suisse reduced its West Pharmaceutical (WST) stake by 5.9% in Q1 2024, selling an estimated $2.91M and leaving 124,664 shares worth $49.3M. The position accounts for 0.05% of the portfolio, ranked #375.
Credit Suisse first reported a position in WST in Q2 2013 and has held it in 44 quarters since. The position peaked at $59.6M in Q2 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.
- Credit Suisse held 124,664 shares of West Pharmaceutical worth $49.3M as of Q1 2024.
- Credit Suisse sold 7,856 West Pharmaceutical shares in Q1 2024, an estimated $2.91M.
- West Pharmaceutical made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #375 holding.
- Credit Suisse first reported a position in West Pharmaceutical in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's West Pharmaceutical position peaked at $59.6M in Q2 2023.
- 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.